BGMD — BG Medicine Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$1.52m
- $1.57m
Annual balance sheet for BG Medicine, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2011 December 31st | 2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 23.9 | 12.8 | 7.75 | 4.12 | 1.52 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.115 | 0.395 | 0.319 | 0.174 | 0.181 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 25.3 | 14.6 | 8.84 | 4.85 | 1.95 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.301 | 0.197 | 0.192 | 0.117 | 0.011 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 26.1 | 15.2 | 9.35 | 5.23 | 2.13 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.2 | 8.31 | 7.35 | 4.58 | 1.18 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5.22 | 14.9 | 10.4 | 4.67 | 1.51 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 20.9 | 0.309 | -1.07 | 0.557 | 0.618 |
| Total Liabilities & Shareholders' Equity | 26.1 | 15.2 | 9.35 | 5.23 | 2.13 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |